These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 11399979

  • 1. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S.
    AIDS; 2001 May 25; 15(8):975-82. PubMed ID: 11399979
    [Abstract] [Full Text] [Related]

  • 2. Reduced intravertebral bone marrow fat in HIV-infected men.
    Huang JS, Mulkern RV, Grinspoon S.
    AIDS; 2002 Jun 14; 16(9):1265-9. PubMed ID: 12045492
    [Abstract] [Full Text] [Related]

  • 3. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.
    Kosmiski L, Kuritzkes D, Hamilton J, Sharp T, Lichtenstien K, Hill J, Eckel R.
    HIV Med; 2003 Jul 14; 4(3):235-40. PubMed ID: 12859322
    [Abstract] [Full Text] [Related]

  • 4. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J.
    Pharmacotherapy; 2006 Feb 14; 26(2):154-61. PubMed ID: 16466321
    [Abstract] [Full Text] [Related]

  • 5. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
    Kosmiski LA, Kuritzkes DR, Lichtenstein KA, Glueck DH, Gourley PJ, Stamm ER, Scherzinger AL, Eckel RH.
    AIDS; 2001 Oct 19; 15(15):1993-2000. PubMed ID: 11600828
    [Abstract] [Full Text] [Related]

  • 6. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
    Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, Cooper DA, Chisholm DJ.
    Diabetes; 2002 Nov 19; 51(11):3163-9. PubMed ID: 12401706
    [Abstract] [Full Text] [Related]

  • 7. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.
    Torriani M, Hadigan C, Jensen ME, Grinspoon S.
    J Appl Physiol (1985); 2003 Sep 19; 95(3):1005-10. PubMed ID: 12766180
    [Abstract] [Full Text] [Related]

  • 8. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A, Miller J, Eisman JA, Cooper DA.
    AIDS; 2001 Apr 13; 15(6):703-9. PubMed ID: 11371684
    [Abstract] [Full Text] [Related]

  • 9. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.
    J Clin Endocrinol Metab; 2000 Jan 13; 85(1):35-41. PubMed ID: 10634360
    [Abstract] [Full Text] [Related]

  • 10. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy.
    Brambilla P, Bricalli D, Sala N, Renzetti F, Manzoni P, Vanzulli A, Chiumello G, di Natale B, Viganò A.
    AIDS; 2001 Dec 07; 15(18):2415-22. PubMed ID: 11740192
    [Abstract] [Full Text] [Related]

  • 11. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S.
    Am J Clin Nutr; 2001 Nov 07; 74(5):679-86. PubMed ID: 11684538
    [Abstract] [Full Text] [Related]

  • 12. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA.
    AIDS; 1998 May 07; 12(7):F51-8. PubMed ID: 9619798
    [Abstract] [Full Text] [Related]

  • 13. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
    Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A.
    Curr HIV Res; 2009 Jul 07; 7(4):454-61. PubMed ID: 19601783
    [Abstract] [Full Text] [Related]

  • 14. BMD is reduced in HIV-infected men irrespective of treatment.
    Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC.
    J Bone Miner Res; 2004 Mar 07; 19(3):402-9. PubMed ID: 15040828
    [Abstract] [Full Text] [Related]

  • 15. Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
    Guaraldi G, Zona S, Cossarizza A, Vernacotola L, Carli F, Lattanzi A, Nardini G, Orlando G, Garlassi E, Termini R, Garau M.
    Int J STD AIDS; 2014 Mar 07; 25(3):207-12. PubMed ID: 24216034
    [Abstract] [Full Text] [Related]

  • 16. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
    Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S.
    J Appl Physiol (1985); 2006 Feb 07; 100(2):609-14. PubMed ID: 16223978
    [Abstract] [Full Text] [Related]

  • 17. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
    Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, Grinspoon S.
    J Clin Endocrinol Metab; 2001 Feb 07; 86(2):504-10. PubMed ID: 11158000
    [Abstract] [Full Text] [Related]

  • 18. Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents.
    Bicudo Bruno Nogueira A, Abreu JM, Mesquita Villela M, Boracini Sanchez AE, Silva Chaves B, Setubal S, Coca Velarde LG, Cruz Filho RAD, Balarini Lima GA, Soares DV.
    J Clin Densitom; 2020 Feb 07; 23(4):623-629. PubMed ID: 30545683
    [Abstract] [Full Text] [Related]

  • 19. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB, Lindegaard B, Obel N, Andersen O, Nielsen H, Gerstoft J.
    HIV Med; 2006 Jan 07; 7(1):38-45. PubMed ID: 16313291
    [Abstract] [Full Text] [Related]

  • 20. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
    Chițu-Tișu CE, Barbu EC, Lazăr M, Bojincă M, Tudor AM, Hristea A, Abagiu AO, Ion DA, Bădărău AI.
    Acta Clin Belg; 2017 Feb 07; 72(1):55-62. PubMed ID: 27724840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.